Literature DB >> 22909446

Mosaic moles and non-familial biparental moles are not caused by mutations in NLRP7, NLRP2 or C6orf221.

L Andreasen1, L Bolund, I Niemann, E S Hansen, L Sunde.   

Abstract

Hydatidiform moles (HMs) most often occur sporadically and are either diploid androgenetic or triploid. The very rare familial recurrent HMs (FRHMs) have been related to NLRP7 and C6orf221 mutations in the mother. FRHMs are most often diploid with both maternal and paternal origin of the molar genome. We have screened a cohort of 11 women with diploid HMs with biparental contributions to the molar genome with regard to mutations in NLRP7, NLRP2, the NLRP gene most homologous to NLRP7, and C6orf221. This was done in order to reveal if mutations in the mentioned genes play a major role in development of non-recurrent biparental moles. Recently, we have shown that eight of these diploid moles consist of two different cell lines. Only one woman had a mutation in the coding DNA sequence of NLRP7, which most likely contributed to HM development. This woman had non-mosaic repeated moles, and she was the only woman in our cohort with FRHM. We found no unequivocal pathogenic mutations in NLRP2 or C6orf221. Our observations suggest that although NLRP7 and C6orf221 mutations are related to diploid biparental FRHMs, neither of these genes, nor NLRP2, are related to diploid HMs with biparental contributions to the molar genome, in general.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22909446     DOI: 10.1093/molehr/gas036

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  7 in total

1.  NLRP7 affects trophoblast lineage differentiation, binds to overexpressed YY1 and alters CpG methylation.

Authors:  Sangeetha Mahadevan; Shu Wen; Ying-Wooi Wan; Hsiu-Huei Peng; Subhendu Otta; Zhandong Liu; Michelina Iacovino; Elisabeth M Mahen; Michael Kyba; Bekim Sadikovic; Ignatia B Van den Veyver
Journal:  Hum Mol Genet       Date:  2013-09-18       Impact factor: 6.150

2.  No evidence for mutations in NLRP7, NLRP2 or KHDC3L in women with unexplained recurrent pregnancy loss or infertility.

Authors:  L Aghajanova; S Mahadevan; S Altmäe; A Stavreus-Evers; L Regan; N Sebire; P Dixon; R A Fisher; I B Van den Veyver
Journal:  Hum Reprod       Date:  2014-11-05       Impact factor: 6.918

3.  No evidence for mutations in NLRP7 and KHDC3L in women with androgenetic hydatidiform moles.

Authors:  Sangeetha Mahadevan; Shu Wen; Alfred Balasa; Gary Fruhman; Julio Mateus; Andrew Wagner; Tarek Al-Hussaini; Ignatia B Van den Veyver
Journal:  Prenat Diagn       Date:  2013-10-04       Impact factor: 3.050

4.  Reproductive Outcomes from Maternal Loss of Nlrp2 Are Not Improved by IVF or Embryo Transfer Consistent with Oocyte-Specific Defect.

Authors:  Sara Arian; Jessica Rubin; Imen Chakchouk; Momal Sharif; Sangeetha K Mahadevan; Hadi Erfani; Katharine Shelly; Lan Liao; Isabel Lorenzo; Rajesh Ramakrishnan; Ignatia B Van den Veyver
Journal:  Reprod Sci       Date:  2020-10-22       Impact factor: 2.924

5.  Expression of maternally derived KHDC3, NLRP5, OOEP and TLE6 is associated with oocyte developmental competence in the ovine species.

Authors:  Daniela Bebbere; Federica Ariu; Luisa Bogliolo; Laura Masala; Ombretta Murrone; Mauro Fattorini; Laura Falchi; Sergio Ledda
Journal:  BMC Dev Biol       Date:  2014-11-25       Impact factor: 1.978

6.  Paternal Hemizygosity in 11p15 in Mole-like Conceptuses: Two Case Reports.

Authors:  Lone Sunde; Helle Lund; Neil J Sebire; Anni Grove; Rosemary A Fisher; Isa Niemann; Eigil Kjeldsen; Lotte Andreasen; Estrid Staehr Hansen; Anders Bojesen; Lars Bolund; Mette Nyegaard
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

7.  NLRP7 is expressed in the ovine ovary and associated with in vitro pre-implantation embryo development.

Authors:  Guangdong Li; Xiuzhi Tian; Dongying Lv; Lu Zhang; Zhenzhen Zhang; Jing Wang; Minghui Yang; Jingli Tao; Teng Ma; Hao Wu; Pengyun Ji; Yingjie Wu; Zhengxing Lian; Wei Cui; Guoshi Liu
Journal:  Reproduction       Date:  2019-11       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.